The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Akhmedzhanova L.T.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

Barinov A.N.

Sechenov First Moscow State Medical University, Moscow

Strokov I.A.

Kafedra nervnykh bolezneĭ

Diabetic and non-diabetic neuropathies in patients with diabetes mellitus

Authors:

Akhmedzhanova L.T., Barinov A.N., Strokov I.A.

More about the authors

Read: 52913 times


To cite this article:

Akhmedzhanova LT, Barinov AN, Strokov IA. Diabetic and non-diabetic neuropathies in patients with diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(4):113‑120. (In Russ.)
https://doi.org/10.17116/jnevro201811841113-120

Recommended articles:
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Painful diabetic poly­neuropathy in patients with cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):64-72
Coca­rnit in complex therapy of diabetic peri­pheral poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):73-81

References:

  1. Maffi P, Secchi A. The Burden of Diabetes: Emerging Data. Dev Ophthalmol. 2017;60:1-5.
  2. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik R, Sosenko J, Zieglar D. Diabetic Neuropathy: a Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154.
  3. Dyck PJ, Albers JW, Andersen H. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity Diabetes. Metab Res Rev. 2011;27(7):620-628.
  4. Barinov AN. Autonomic neuropathy in diabetes mellitus and metabolic syndrome. Effectivnaya pharmacoterapiya. 2017;2:40-52. (In Russ.)
  5. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic neuropathies. Philadelphia: Elsevier Sounders-th ed; 2005;2:1951-1991.
  6. Rota E, Morelli N. Entrapment neuropathies in diabetes mellitus. World Diabetes. 2016;15(7):17:342-353.
  7. Horinouchi S, Deguchi T, Arimura K, Arimura A, Dochi Y, Uto T, Nakamura T, Arimura Y, Nishio Y, Takashima H. Median neuropathy at the wtist as an early manifestation of diabetic neuropathy. J Diabetes Investig. 2014;5(6):709-713.
  8. Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi J, Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002;249:569-575.
  9. Isaikin AI, Kaverina AV, Zinov’eva OE, Akhmedzhanova LT. Diabetic proximal neuropathy. Meditsinskiy sovet. 2014;2:46-51. (In Russ.)
  10. Rajabally YA, Stettner M, Kieseier BC, Hartung H, Malik R. CIDP and other inflammatory neuropathies in diabetes — diagnosis and management. Nat Rev Neurol. 2017;13(10):599-611.
  11. Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — first revision. European J Neurol. 2010;17(3):356-363.
  12. Stettner M, Hinrichs L, Guthoff R, Bairov S, Petropoulos IN, Warnke C, Hartung H-P, Malik RA, Kieseier BC. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol. 2016;3(2):88-100.
  13. Strokov IA, Akhmedzhanova LT, Yakhno NN. Antigangliosedes GM1 and GD1B antibodies in chronic inflammatory demyelinating polyneuropathy. Neurological Journal. 2009;3(14):10-15. (In Russ.)
  14. Strokov IA, Akhmedzhanova LT, Shor YM. The Guillain—Barre syndrome in patient with diabetes mellitus. Neurological Journal. 2010;15(1):39-45. (In Russ.)
  15. Niafar M, Hai F, Porhomayon J, Nader ND. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern Emerg Med. 2015;10:93-102.
  16. Olt S, Oznas О. Investigation of the vitamin B12 deficiency with peripheral neuropathy in patients with type 2 diabetes mellitus treated using metformin. North Clin Istanb. 2017;4(3):233-236.
  17. Gupta К, Jain А, Rohatgi А. An observational study of vitamin b12 levels and peripheral neuropathy profile in patients of diabetes mellitus on metformin therapy. Diabetes Metab Syndr. 2017;25.
  18. Singh AK, Kumar A, Karmakar D, Jha RK. Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med. 2013;59(4):253-257.
  19. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy the SYDNEY 2 trial. Diabetes Care. 2006;29:2365-2370.
  20. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alphalipoic acid: a meta-analysis. Diabet Med. 2004;21:114-121.
  21. Almeida O, Marsh K, Alfonso H, Flicker L, Davis T, Hankey G. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann Neurol. 2010;68:503-510.
  22. Group VTS. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010;9:855-865.
  23. Almeida O, Ford A, Hirani V, Singh V, van Bockxmeer F, McCaul K, Flicker L. B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial. The British Journal of Psychiatry. 2014; 205(6):450-457.
  24. Ford A, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida O. The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life. Trials. 2010;11:8.
  25. Lee PY, Tsai PS, Huang YH, Huang CJ. Inhibition of tolllike receptor-4, nuclear factor-kappaB and mitogen-activated protein kinase by lignocaine may involve voltage-sensitive sodium channels. Clin Exp Pharmacol Physiol. 2008;35:1052-1058.
  26. Lotan I, Hellman MA, Steiner I. Diagnostic criteria of chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus. Acta Neurol Scand. 2015;132:278-283.
  27. Van der Wal1 S, van den Heuvel1 S, Radema S, van Berkum BF, Vaneker M, Steegers MA, Scheffer GJ, Vissers KC. The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. Eur J Pain. 2016;20(5):655-674. https://doi.org/10.1002/ejp
  28. Werdehausen R, Kremer D, Brandenburger T, Schlösser L, Jadasz J., Küry P., Bauer I., Aragón C., Eulenburg V., Hermanns H. Lidocaine metabolites inhibit glycine transporter 1: A novel mechanism for the analgesic action of systemic lidocaine? Anesthesiology. 2012;116(1):147-158.
  29. Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel R. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomized, double-blind, placebo-controlled clinical trial. Exp Clin Endocrinol Diabetes. 2008;116(10):600-605.
  30. Afonina JA, Strokov IA, Ametov AS, Voychic EA. Treatment tunnel neuropathies of the hands in patients with diabetes mellitus. RMJ. 2008;16(12):1621-1625. (In Russ.)
  31. Bril V, Blanchette C, Noone JM, Runken M, Gelinas D, Russell. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. J Diabetes Complications. 2016;30:1401-1407.
  32. Hahn AF, Hartung H, Dick P. Chronic inflammatory demyelinating polyneuropathy. Peripheral Neuropathy. Ed. P. Dick, PK. Thomas. Philadelphia: Elsevier Sounders-th ed. 2005;2:2221-2255.
  33. Barinov AN, Akhmedzhanova LT, Mahinov KA. The algorithms of diagnostics and treatment of neuropathic pain in lesion of the peripheral nervous system. RMJ. 2016;3:154-162. (In Russ.)
  34. Makhinov KA, Barinov AN. The pathogenic treatment of neuropathic pain in diabetic polyneuropathy. Neurological Journal. 2015;20(2):4-13. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.